Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
-
Corner Expands Leadership Team, Appointing Michael Sonnenshein Partner & Group President
-
Encompass Health to build 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia
-
Autodesk to present at upcoming investor conferences
-
Texas Super Kings Announce BONbLOC Technologies USA Inc. as Official AI Partner and Non-Leading Arm Sponsor
-
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
-
CoStar Group to Acquire Zonda, the Leader in New Home Data, Analytics, and Online Marketplaces
-
REX Shares Launches T-REX 2X TE (TEUP) ETF
-
Everlert, Inc. (OTC: EVLI), Appoints Dr. Criss Capps as Vice President of Mining, Exploration and Geology
-
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
-
Visit Tacoma-Pierce County Launches "Art of the Game" Glass Art Scavenger Hunt for Summer 2026
-
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation
-
Siesta Valley Bowl Announces Inaugural Season, Opening June 5th with Proto-Punk Legend Jonathan Richman
-
Cosign Enters Evans Market to Address Renter Approval Gaps as Vacancies Rise
-
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
-
CVS Health recognized for technology that improves medication safety and patient care
-
ChargePoint and Powers Parts Partner Simplify Fast Charging for Transit Operators
-
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
-
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
-
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
-
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
-
Raydium Surpasses $1T in Volume Following Robinhood and Revolut Listings
-
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
-
Max Power Closes $25 Million Strategic Investment From Eric Sprott To Accelerate Commercial Evaluation at Lawson
-
Lim Meng Hoong Attends Science x AI Summit 2026, Focusing On New Trends In AI Industry Collaboration
-
HomesToLife Delivers 36% Increase in Q1 2026 Net Profit to $3.2 Million on Export Growth and Stronger Margins
-
QTREX Announces Pricing of a $10 Million Private Placement of Ordinary Shares with a New Fundamental Institutional Investor
-
DarkIris Announces Commercial Launch of AIGC Video Platform, video.aideptus.com, Integrating ByteDance’s Seedance 2.0 Model
-
Research Presented by The US Oncology Network Demonstrates How Community Practices Are Expanding Patient Access Through APP‑Led Models at ASCO 2026
-
SunPower Achieves High NPS Score from Starbucks
-
Cosign Launches Across Upstate South Carolina as Qualified Renters Keep Getting Turned Away
-
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
-
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
-
Hammond Power Solutions Declares Quarterly Dividend
-
Titan Aircraft Investments Completes Sale of Boeing 767-300ERF to Cargo Aircraft Management, Inc.
-
Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology
-
Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds
-
Okta to Present at Upcoming Investor Conferences
-
Gentex Announces Second Quarter 2026 Cash Dividend
-
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
-
Injured Workers Rally Across Ontario on Monday June 1st In Face Of Attacks To Workers Comp System
-
The Elmet Group Co. Reports First Quarter 2026 Results
-
Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy
-
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
-
NextBoat Inc. Completes Corporate Rebrand and Begins Trading Under "NXB" on NYSE American
-
Jack Henry Leaders to Present at Upcoming Investor Conferences
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Best Buy Announces Regular Quarterly Cash Dividend
-
FOREWARN to Provide Identity Verification Services to Hawaii REALTORS® to Promote Agent Safety
-
UPDF Redefines Digital Workflow With AI Powered Productivity Tools
